Wednesday, July 8, 2026

pharma · Autoimmune Epilepsy · OPTN

Option Therapeutics

Option Therapeutics trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.

CARSON CITY, NV, USA HQ
2023 Founded
2 Employees
Public company Type
OPTN · NYSE Ticker
Company details
Status
Public
HQ
CARSON CITY, NV, USA
Founded
2023
Employees
2
Programs
1
Drugs
1
Patents
10
Intelligence · Clinical Trials

Option Therapeutics clinical trials

Registry index of 1 ClinicalTrials.gov studies linked to Option Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Option Therapeutics trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

1 updates

Latest clinical program signals indexed for Option Therapeutics.

  1. Intravenous Immunoglobulin — Phase 3

    Clinical update

Trial registry

1 studies